Abstract
Over the last decade, the field of lung biology has evolved considerably due to many advancements, including the advent of single-cell RNA (scRNA) sequencing, induced pluripotent stem cell (iPSC) reprogramming, and 3D cell and tissue culture. Despite rigorous research and tireless efforts, chronic pulmonary diseases remain the third leading cause of death globally, with transplantation being the only option for treating end-stage disease. This chapter will introduce the broader impacts of understanding lung biology in health and disease, provide an overview of lung physiology and pathophysiology, and summarize the key takeaways from each chapter describing engineering translational models of lung homeostasis and disease. This book is divided into broad topic areas containing chapters covering basic biology, engineering approaches, and clinical perspectives related to (1) the developing lung, (2) the large airways, (3) the mesenchyme and parenchyma, (4) the pulmonary vasculature, and (5) the interface between lungs and medical devices. Each section highlights the underlying premise that engineering strategies, when applied in collaboration with cell biologists and pulmonary physicians, will address critical challenges in pulmonary health care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Forum of International Respiratory Societies. The Global Impact of Respiratory Disease – Second Edition. Sheffield, European Respiratory Society, 2017.
National Center for Health Statistics. Underlying Cause of Death 1999–2019 on CDC WONDER Online Database, released in 2020.
Deterding, R. R., DeBoer, E. M., Cidon, M. J., Robinson, T. E., Warburton, D., Deutsch, G. H., & Young, L. R. (2019). Approaching Clinical Trials in Childhood Interstitial Lung Disease and Pediatric Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, 200(10), 1219–1227. https://doi.org/10.1164/rccm.201903-0544CI
George, P. M., Wells, A. U., & Jenkins, R. G. (2020). Pulmonary fibrosis and COVID-19: The potential role for antifibrotic therapy. The Lancet. Respiratory Medicine, 8(8), 807–815. https://doi.org/10.1016/S2213-2600(20)30225-3
Michalski, J. E., Kurche, J. S., & Schwartz, D. A. (2022). From ARDS to pulmonary fibrosis: The next phase of the COVID-19 pandemic? Translational Research, 241, 13–24. https://doi.org/10.1016/j.trsl.2021.09.001
Gibson, P. G., Qin, L., & Puah, S. H. (2020). COVID-19 acute respiratory distress syndrome (ARDS): Clinical features and differences from typical pre-COVID-19 ARDS. The Medical Journal of Australia, https://doi.org/10.5694/mja2.50674. https://doi.org/10.5694/mja2.50674
Ley, B., Collard, H. R., & King, T. E. (2011). Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, 183(4), 431–440. https://doi.org/10.1164/rccm.201006-0894CI
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., Lederer, D. J., Nathan, S. D., Pereira, C. A., Sahn, S. A., Sussman, R., Swigris, J. J., Noble, P. W., & ASCEND Study Group. (2014). A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. The New England Journal of Medicine, 370(22), 2083–2092. https://doi.org/10.1056/NEJMoa1402582
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., Kim, D. S., Kolb, M., Nicholson, A. G., Noble, P. W., Selman, M., Taniguchi, H., Brun, M., Le Maulf, F., Girard, M., … Collard, H. R. (2014). Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. New England Journal of Medicine, 370(22), 2071–2082. https://doi.org/10.1056/NEJMoa1402584
Saidi, R. F., & Hejazii Kenari, S. K. (2014). Challenges of organ shortage for transplantation: Solutions and opportunities. International Journal of Organ Transplantation Medicine, 5(3), 87–96.
Health Resources & Services Administration. (2022). Organ Donation Statistics | organdonor.gov. https://www.organdonor.gov/learn/organ-donation-statistics
Miller, A. J., & Spence, J. R. (2017). In Vitro Models to Study Human Lung Development, Disease and Homeostasis. Physiology, 32(3), 246–260. https://doi.org/10.1152/physiol.00041.2016
Hogan, B. L. M. (2018). Integrating Mechanical Force into Lung Development. Developmental Cell, 44(3), 273–275. https://doi.org/10.1016/j.devcel.2018.01.015
Li, J., Wang, Z., Chu, Q., Jiang, K., Li, J., & Tang, N. (2018). The Strength of Mechanical Forces Determines the Differentiation of Alveolar Epithelial Cells. Developmental Cell, 44(3), 297-312.e5. https://doi.org/10.1016/j.devcel.2018.01.008
Warburton, D., El-Hashash, A., Carraro, G., Tiozzo, C., Sala, F., Rogers, O., De Langhe, S., Kemp, P. J., Riccardi, D., Torday, J., Bellusci, S., Shi, W., Lubkin, S. R., & Jesudason, E. (2010). Lung organogenesis. Current Topics in Developmental Biology, 90, 73–158. https://doi.org/10.1016/S0070-2153(10)90003-3.
Sicard, D., Haak, A. J., Choi, K. M., Craig, A. R., Fredenburgh, L. E., & Tschumperlin, D. J. (2018). Aging and anatomical variations in lung tissue stiffness. American Journal of Physiology - Lung Cellular and Molecular Physiology, 314(6), L946–L955. https://doi.org/10.1152/ajplung.00415.2017
Safshekan, F., Tafazzoli-Shadpour, M., Abdouss, M., Behgam Shadmehr, M., & Ghorbani, F. (2017). Investigation of the Mechanical Properties of the Human Tracheal Cartilage. Tanaffos, 16(2), 107–114.
Kia’i, N., & Bajaj, T. (2022). Histology, Respiratory Epithelium. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK541061/
Gartner, L. (2021). Respiratory System. Textbook of Histology, 15, 355-378.e2
Busch, S. M., Lorenzana, Z., & Ryan, A. L. (2021). Implications for Extracellular Matrix Interactions with Human Lung Basal Stem Cells in Lung Development, Disease, and Airway Modeling. Frontiers in Pharmacology, 12, 645858. https://doi.org/10.3389/fphar.2021.645858
Yuen, E., Gudis, D. A., Rowan, N. R., Nguyen, S. A., & Schlosser, R. J. (2021). Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists. American Journal of Rhinology & Allergy, 35(1), 122–131. https://doi.org/10.1177/1945892420947929
Calvert, B. A., Quiroz, E. J., Lorenzana, Z., Doan, N., Kim, S., Senger, C. N., Wallace, W. D., Salomon, M. P., Henley, J., & Ryan, A. L. (2022). Neutrophilic inflammation promotes SARS-CoV-2 infectivity and augments the inflammatory responses in airway epithelial cells. BioRxiv: The Preprint Server for Biology, 2021.08.09.455472. https://doi.org/10.1101/2021.08.09.455472
Wang, R., Hume, A. J., Beermann, M. L., Simone-Roach, C., Lindstrom-Vautrin, J., Le Suer, J., Huang, J., Olejnik, J., Villacorta-Martin, C., Bullitt, E., Hinds, A., Ghaedi, M., Rollins, S., Werder, R. B., Abo, K. M., Wilson, A. A., Mühlberger, E., Kotton, D. N., & Hawkins, F. J. (2022). Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection. American Journal of Physiology - Lung Cellular and Molecular Physiology, 322(3), L462–L478. https://doi.org/10.1152/ajplung.00397.2021
Widdicombe, J. G., & Pack, R. J. (1982). The Clara Cell. European Journal of Respiratory Diseases, 63(3), 202–220.
Suki, B., Stamenovic, D., & Hubmayr, R. (2011). Lung Parenchymal Mechanics. Comprehensive Physiology, 1(3), 1317–1351. https://doi.org/10.1002/cphy.c100033
Burgstaller, G., Oehrle, B., Gerckens, M., White, E. S., Schiller, H. B., & Eickelberg, O. (2017). The instructive extracellular matrix of the lung: Basic composition and alterations in chronic lung disease. European Respiratory Journal, 50(1), 1601805. https://doi.org/10.1183/13993003.01805-2016
Richeldi, L., Collard, H. R., & Jones, M. G. (2017). Idiopathic pulmonary fibrosis. The Lancet, 389(10082), 1941–1952. https://doi.org/10.1016/S0140-6736(17)30866-8
Nasri, A., Foisset, F., Ahmed, E., Lahmar, Z., Vachier, I., Jorgensen, C., Assou, S., Bourdin, A., & De Vos, J. (2021). Roles of Mesenchymal Cells in the Lung: From Lung Development to Chronic Obstructive Pulmonary Disease. Cells, 10(12), 3467. https://doi.org/10.3390/cells10123467
McCulley, D., Wienhold, M., & Sun, X. (2015). The Pulmonary Mesenchyme Directs Lung Development. Current Opinion in Genetics & Development, 32, 98–105. https://doi.org/10.1016/j.gde.2015.01.011
Ruffenach, G., Hong, J., Vaillancourt, M., Medzikovic, L., & Eghbali, M. (2020). Pulmonary hypertension secondary to pulmonary fibrosis: Clinical data, histopathology, and molecular insights. Respiratory Research, 21(1), 303. https://doi.org/10.1186/s12931-020-01570-2
Burgess, J. K., Mauad, T., Tjin, G., Karlsson, J. C. (2016). Westergren-Thorsson, G. The extracellular matrix – the under-recognized element in lung disease? The Journal of Pathology, 240(4), 397–409. https://doi.org/10.1002/path.4808
Caracena, T., Blomberg, R., Hewawasam, R. S., Fry, Z. E., Riches, D. W. H., & Magin, C. M. (2022). Alveolar epithelial cells and microenvironmental stiffness synergistically drive fibroblast activation in three-dimensional hydrogel lung models. Biomaterials Science. https://doi.org/10.1039/D2BM00827K
Studies, I. of M. (US) C. on E. and L. I. R. to the I. of W. in C., Mastroianni, A. C., Faden, R., & Federman, D. (1994). NIH Revitalization Act of 1993 Public Law 103-43. In Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies: Volume I. National Academies Press (US). http://www.ncbi.nlm.nih.gov/books/NBK236531/
Shah, K., McCormack, C. E., & Bradbury, N. A. (2014). Do you know the sex of your cells? American Journal of Physiology – Cell Physiology, 306(1), C3–C18. https://doi.org/10.1152/ajpcell.00281.2013
James, B. D., & Allen, J. B. (2021). Sex-Specific Response to Combinations of Shear Stress and Substrate Stiffness by Endothelial Cells In Vitro. Advanced Healthcare Materials, 10(18), 2100735. https://doi.org/10.1002/adhm.202100735
Alysandratos, K.-D., Russo, S. J., Petcherski, A., Taddeo, E. P., Acín-Pérez, R., Villacorta-Martin, C., Jean, J. C., Mulugeta, S., Rodriguez, L. R., Blum, B. C., Hekman, R. M., Hix, O. T., Minakin, K., Vedaie, M., Kook, S., Tilston-Lunel, A. M., Varelas, X., Wambach, J. A., Cole, F. S., … Kotton, D. N. (2021). Patient-specific iPSCs carrying an SFTPC mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung disease. Cell Reports, 36(9), 109636. https://doi.org/10.1016/j.celrep.2021.109636
Aguado, B. A., Grim, J. C., Rosales, A. M., Watson-Capps, J. J., & Anseth, K. S. (2018). Engineering precision biomaterials for personalized medicine. Science Translational Medicine, 10(424), eaam8645. https://doi.org/10.1126/scitranslmed.aam8645
Guenthart, B. A., O’Neill, J. D., Kim, J., Queen, D., Chicotka, S., Fung, K., Simpson, M., Donocoff, R., Salna, M., Marboe, C. C., Cunningham, K., Halligan, S. P., Wobma, H. M., Hozain, A. E., Romanov, A., Vunjak-Novakovic, G., & Bacchetta, M. (2019). Regeneration of severely damaged lungs using an interventional cross-circulation platform. Nature Communications, 10, 1985. https://doi.org/10.1038/s41467-019-09908-1
3D Systems Announces Acquisition of Volumetric Biotechnologies. (2021, October 27). 3D Systems. https://www.3dsystems.com/press-releases/3d-systems-announces-acquisition-volumetric-biotechnologies
Listek, V. (2021, November 1). 3D Systems Pursuing Breakthrough Advances in Bioprinting, Acquires Volumetric. 3DPrint.Com | The Voice of 3D Printing/Additive Manufacturing. https://3dprint.com/286334/3d-systems-pursuing-breakthrough-advances-in-bioprinting-buys-jordan-millers-volumetric/
Volumetric to Be Acquired by 3D Systems to Advance Tissue and Organ Manufacturing. (2021, October 27). Business Wire. https://www.businesswire.com/news/home/20211027006115/en/Volumetric-to-Be-Acquired-by-3D-Systems-to-Advance-Tissue-and-Organ-Manufacturing
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Tanneberger, A.E., Weiss, D.J., Magin, C.M. (2023). An Introduction to Engineering and Modeling the Lung. In: Magin, C.M. (eds) Engineering Translational Models of Lung Homeostasis and Disease. Advances in Experimental Medicine and Biology, vol 1413. Springer, Cham. https://doi.org/10.1007/978-3-031-26625-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-031-26625-6_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-26624-9
Online ISBN: 978-3-031-26625-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)